{"id":24472,"date":"2022-07-29T02:42:10","date_gmt":"2022-07-29T06:42:10","guid":{"rendered":"https:\/\/massivebio.com\/?p=12501"},"modified":"2025-10-24T23:49:37","modified_gmt":"2025-10-24T20:49:37","slug":"massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor","status":"publish","type":"post","link":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/","title":{"rendered":"Massive Bio d\u00fcnya \u00e7ap\u0131nda s\u0131n\u0131f\u0131n\u0131n en iyi yapay zeka \u015firketleriyle rekabet ediyor."},"content":{"rendered":"\r\n<p><strong><strong>Massive Bio, 100.000 kanser hastas\u0131na ula\u015fmak i\u00e7in ki\u015fiselle\u015ftirilmi\u015f klinik \u00e7al\u0131\u015fma e\u015fle\u015ftirme teknolojisini ba\u015flat\u0131yor.<\/strong><\/strong><\/p>\r\n\r\n\r\n\r\n<p>Yapay Zeka (YZ) kullan\u0131m\u0131, sa\u011fl\u0131k sekt\u00f6r\u00fc de dahil olmak \u00fczere \u00e7e\u015fitli alanlarda devrim yaratm\u0131\u015ft\u0131r. \u0130nsan ya\u015fam\u0131n\u0131n sa\u011fl\u0131\u011f\u0131 ve kolay y\u00f6netimi, h\u0131zla geli\u015fen bu teknoloji i\u00e7in hayati \u00f6neme sahiptir. Sa\u011fl\u0131k sekt\u00f6r\u00fcnde bile \u00e7\u00f6z\u00fcme ula\u015f\u0131lamam\u0131\u015f sorunlar varsa durum daha da karma\u015f\u0131kt\u0131r, \u00f6rne\u011fin kanser gibi. Mevcut tedavi y\u00f6ntemleri kanserle m\u00fccadelede etkisiz kalmaktad\u0131r, bu nedenle yeni tedavi y\u00f6ntemleri tek \u00e7\u00f6z\u00fcm olacakt\u0131r. Ayr\u0131ca, bu tedavilere ula\u015fmak i\u00e7in klinik \u00e7al\u0131\u015fmalara kat\u0131lmak zorlu bir g\u00f6revdir, bu alanda hizmet vermek isteyen \u015firketler ters ak\u0131nt\u0131da y\u00fczmelidir. &#8220;Kanseri yok etmek&#8221; amac\u0131yla kurulan Massive Bio, geli\u015ftirdi\u011fi Yapay Zeka teknolojisi sayesinde bu misyonu ba\u015far\u0131yla tamamlamaktad\u0131r.<\/p>\r\n\r\n\r\n\r\n<p><strong><strong>Sistemik Molek\u00fcler Profil Olu\u015fturma<\/strong><\/strong><\/p>\r\n\r\n\r\n\r\n<p>\u015eirket, kanser hastalar\u0131na zaman\u0131nda ve \u00f6l\u00e7eklendirilebilir ki\u015fiselle\u015ftirilmi\u015f hizmetler sunarak yeni nesil dizileme testi (NGS) yoluyla kapsaml\u0131 bir molek\u00fcler profil olu\u015fturuyor. Massive Bio&#8217;nun yapay zeka algoritmalar\u0131n\u0131 kullanarak, hastalar kanser verilerini girdi\u011finde, Massive Bio&#8217;nun algoritmalar\u0131 mevcut klinik \u00e7al\u0131\u015fmalar aras\u0131ndan en iyi tedaviyi h\u0131zla tespit ediyor. Bu s\u00fcrecin hassas do\u011fas\u0131 nedeniyle, t\u00fcm s\u00fcre\u00e7 gizli kal\u0131yor.<\/p>\r\n\r\n\r\n\r\n<p><strong><strong>HIPAA, GDPR ve Avrupa Klinik \u00c7al\u0131\u015fma Y\u00f6netmeliklerine Uygun<\/strong><\/strong><\/p>\r\n\r\n\r\n\r\n<p>Massive Bio i\u00e7in hastalar\u0131n gizlili\u011fi en \u00fcst d\u00fczeyde \u00f6nem ta\u015f\u0131r. Hi\u00e7bir t\u0131bbi bilgi a\u00e7\u0131klanmaz. Algoritmalar\u0131m\u0131z, hastalar bize raporlar\u0131n\u0131 g\u00f6nderdikten sonra bilgilerini filtreler ve t\u00fcm ki\u015fisel veriler \u015fifrelenir. Sonra CTMS (Klinik \u00c7al\u0131\u015fma E\u015fle\u015ftirme Sistemi), hastalar\u0131m\u0131z\u0131n verilerini klinik \u00e7al\u0131\u015fmalarla e\u015fle\u015ftirmeye ba\u015flar.<\/p>\r\n\r\n\r\n\r\n<p>Veri toplama hastalar\u0131n r\u0131zas\u0131yla yap\u0131l\u0131r. T\u00fcm \u00e7al\u0131\u015fmalar HIPAA (Sa\u011fl\u0131k Sigortas\u0131 Ta\u015f\u0131nabilirlik ve Sorumluluk Yasas\u0131), GDPR (Genel Veri Koruma T\u00fcz\u00fc\u011f\u00fc) ve Avrupa klinik \u00e7al\u0131\u015fma y\u00f6netmeliklerine uygun olarak yap\u0131l\u0131r.<\/p>\r\n\r\n\r\n\r\n<p><strong><strong>PNL ve Bilgisayarl\u0131 G\u00f6rme ile Teknoloji<\/strong><\/strong><\/p>\r\n\r\n\r\n\r\n<p>Massive Bio, NLP (Do\u011fal Dil \u0130\u015fleme) ve bilgisayarl\u0131 g\u00f6rme dahil olmak \u00fczere u\u00e7tan uca yapay zeka algoritmalar\u0131 kullanarak d\u00fcnyan\u0131n d\u00f6rt bir yan\u0131ndaki klinik \u00e7al\u0131\u015fma verilerini hastalar\u0131n verileriyle e\u015fle\u015ftiriyor. Massive Bio&#8217;nun u\u00e7tan uca AI teknolojisi sayesinde hastalar, en uygun tedavi y\u00f6ntemini birka\u00e7 dakika i\u00e7inde se\u00e7ebilmektedir.<\/p>\r\n\r\n\r\n\r\n<p>Bu \u00f6zellikler, Massive Bio&#8217;ya \u00f6zg\u00fcd\u00fcr. Sa\u011fl\u0131k end\u00fcstrisi i\u00e7in ola\u011fan\u00fcst\u00fc teknoloji hizmetleri ve b\u00fcy\u00fck veri platformu sunarak d\u00fcnya genelinde klinik \u00e7al\u0131\u015fmalardaki t\u0131kan\u0131kl\u0131klar\u0131 ortadan kald\u0131r\u0131yor. Bu program, kanser hastalar\u0131n\u0131n ya\u015fam kalitesini iyile\u015ftirmeyi hedeflemektedir. Ayn\u0131 zamanda hastane a\u011flar\u0131na ve ila\u00e7 \u015firketlerine hizmet vermektedir. \u015eu anda, Massive Bio, 12 \u00fclkede 60.000 kanser hastas\u0131na ula\u015fm\u0131\u015f durumdad\u0131r. Daha geni\u015f co\u011frafi alanlara h\u0131zla yay\u0131lmay\u0131 ve uygun tedavi y\u00f6ntemlerini bulmay\u0131 hedeflemektedir.<\/p>\r\n\r\n\r\n\r\n<p>Teknoloji, b\u00fcy\u00fck veri ve hizmet ile birle\u015fen bu uyumlu \u00fc\u00e7l\u00fc, Massive Bio&#8217;nun son derece kararl\u0131, tutkulu ve \u00f6zverili ilkesinin temelini olu\u015fturuyor. Bu \u00fc\u00e7l\u00fcn\u00fcn m\u00fckemmel uyumu sayesinde, &#8220;kanser, tarihin gizli sayfalar\u0131nda g\u00f6m\u00fcl\u00fc kalm\u0131\u015f&#8221; haberini bir sabah uyanarak alaca\u011f\u0131z.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Massive Bio, 100.000 kanser hastas\u0131na ula\u015fmak i\u00e7in ki\u015fiselle\u015ftirilmi\u015f klinik \u00e7al\u0131\u015fma e\u015fle\u015ftirme teknolojisini ba\u015flat\u0131yor. Yapay Zeka (YZ) kullan\u0131m\u0131, sa\u011fl\u0131k sekt\u00f6r\u00fc de dahil olmak \u00fczere \u00e7e\u015fitli alanlarda devrim yaratm\u0131\u015ft\u0131r. \u0130nsan ya\u015fam\u0131n\u0131n sa\u011fl\u0131\u011f\u0131 ve kolay y\u00f6netimi, h\u0131zla geli\u015fen bu teknoloji i\u00e7in hayati \u00f6neme sahiptir. Sa\u011fl\u0131k sekt\u00f6r\u00fcnde bile \u00e7\u00f6z\u00fcme ula\u015f\u0131lamam\u0131\u015f sorunlar varsa durum daha da karma\u015f\u0131kt\u0131r, \u00f6rne\u011fin kanser gibi&#8230;.<\/p>\n","protected":false},"author":11,"featured_media":34113,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2028],"tags":[],"class_list":["post-24472","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-haber"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>D\u00fcnya \u00c7ap\u0131nda ki En \u0130yi Yapay Zeka \u015eirketleriyle Rekabet<\/title>\n<meta name=\"description\" content=\"Massive Bio lance une technologie personnalis\u00e9e d&#039;appariement de la recherche clinique pour atteindre 100 000 patients atteints de cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Massive Bio d\u00fcnya \u00e7ap\u0131nda s\u0131n\u0131f\u0131n\u0131n en iyi yapay zeka \u015firketleriyle rekabet ediyor. %\" \/>\n<meta property=\"og:description\" content=\"Massive Bio lance une technologie personnalis\u00e9e d&#039;appariement de la recherche clinique pour atteindre 100 000 patients atteints de cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-29T06:42:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-24T20:49:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2022\/07\/news-cover-image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"599\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"D\u00fcnya \u00c7ap\u0131nda ki En \u0130yi Yapay Zeka \u015eirketleriyle Rekabet","description":"Massive Bio lance une technologie personnalis\u00e9e d'appariement de la recherche clinique pour atteindre 100 000 patients atteints de cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/","og_locale":"en_US","og_type":"article","og_title":"Massive Bio d\u00fcnya \u00e7ap\u0131nda s\u0131n\u0131f\u0131n\u0131n en iyi yapay zeka \u015firketleriyle rekabet ediyor. %","og_description":"Massive Bio lance une technologie personnalis\u00e9e d'appariement de la recherche clinique pour atteindre 100 000 patients atteints de cancer.","og_url":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2022-07-29T06:42:10+00:00","article_modified_time":"2025-10-24T20:49:37+00:00","og_image":[{"width":800,"height":599,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2022\/07\/news-cover-image.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Massive Bio d\u00fcnya \u00e7ap\u0131nda s\u0131n\u0131f\u0131n\u0131n en iyi yapay zeka \u015firketleriyle rekabet ediyor.","datePublished":"2022-07-29T06:42:10+00:00","dateModified":"2025-10-24T20:49:37+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/"},"wordCount":578,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2022\/07\/news-cover-image.webp","articleSection":["Haber"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/","url":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/","name":"D\u00fcnya \u00c7ap\u0131nda ki En \u0130yi Yapay Zeka \u015eirketleriyle Rekabet","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2022\/07\/news-cover-image.webp","datePublished":"2022-07-29T06:42:10+00:00","dateModified":"2025-10-24T20:49:37+00:00","description":"Massive Bio lance une technologie personnalis\u00e9e d'appariement de la recherche clinique pour atteindre 100 000 patients atteints de cancer.","breadcrumb":{"@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2022\/07\/news-cover-image.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2022\/07\/news-cover-image.webp","width":800,"height":599,"caption":"news cover image"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/tr\/massive-bio-dunya-capinda-sinifinin-en-iyi-yapay-zeka-sirketleriyle-rekabet-ediyor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"Haber","item":"https:\/\/massivebio.com\/tr\/haber\/"},{"@type":"ListItem","position":3,"name":"Massive Bio d\u00fcnya \u00e7ap\u0131nda s\u0131n\u0131f\u0131n\u0131n en iyi yapay zeka \u015firketleriyle rekabet ediyor."}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/24472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=24472"}],"version-history":[{"count":1,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/24472\/revisions"}],"predecessor-version":[{"id":34114,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/24472\/revisions\/34114"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/34113"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=24472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=24472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=24472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}